DUBLIN--(BUSINESS WIRE)--The "United States Healthcare Fraud Detection Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering.
The US Healthcare Fraud Detection market studied was valued at USD 337.41 million in 2018, and is expected to reach USD 1,254.48 million by 2024, with an anticipated CAGR of 24.47%, during the forecast period (2019-2024).
The major factors attributing to the growth of the US healthcare fraud detection market are increasing fraudulent activities in the US healthcare, growing pressure to increase in operations efficiency and reduce healthcare spending, and prepayment review model.
For instance, as per the National Health Care Anti-Fraud Association stated that health insurance frauds in the United States cost around USD 80 billion per year to the consumers. Criminals are looking forward to profit from the people across the country. As most of the people in the country are having health insurance, free medical treatments or complimentary consultation offers are being stolen.
Such cases of frauds in health insurance are causing damages to the medical history of people. A few years back, it was difficult for the healthcare providers to identify the fraud, as criminals were playing with all types of patient identifications and insurance information.
Due to such frauds, patients are compelled to pay higher premiums and their medical history is compromised. Therefore, the US healthcare department is currently more focused on the reduction of such cases by implementing fraud detection technology. Therefore, it is believed that due to the rising fraudulent activities in the US healthcare department, the market studied may grow in the future.
Key Market Trends
Review of Insurance Claims is Expected to Hold the Major Share
The healthcare fraud detection solution plays a major role in the review of insurance claims, as most of the fraud cases occur while claiming the insurance. As per the estimates of the National Health Care Anti-Fraud Association (NHCAA), health care fraud costs the United States around USD 68 billion annually. Health insurance fraud is a type of fraud in which false or misleading information is provided to a health insurance company in an attempt to have them pay unauthorized benefits to the policy holder another party or the entity providing services. The offense can be committed by the insured individual or the provider of health services.
Most health insurances include specific benefits and health insurance fraud practices, such as overbilling for the type of services received, rob consumers of these benefits. A central objective of the recent US healthcare policy reform, most notably the Affordable Care Act's (ACA) Health Insurance Marketplace, has been to increase access to stable, affordable health insurance. Owing to the aforementioned factors, the review of insurance claims segment is expected to grow exponentially in the US healthcare fraud detection market.
The healthcare fraud detection market is moderately competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. With the rising adoption of Healthcare IT and the increasing number of fraud cases, few other smaller players are expected to enter into the market in the coming years.
Some of the major players of the market are Conduent, DXC Technology Company, EXL (Scio Health Analytics), International Business Machines Corporation (IBM), and Mckesson are among others.
Key Topics Covered
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Fraudulent Activities in the US Healthcare
4.2.2 Growing Pressure to Increase in Operations Efficiency & Reduce Healthcare Spending
4.2.3 Prepayment Review Model
4.3 Market Restraints
4.3.1 Lack of Skilled Healthcare IT Labor in the Country
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Type
5.1.1 Descriptive Analytics
5.1.2 Predictive Analytics
5.1.3 Prescriptive Analytics
5.2 By Application
5.2.1 Review of Insurance Claims
5.2.2 Payment Integrity
5.3 By End-user
5.3.1 Private Insurance Payers
5.3.2 Government Agencies
5.3.3 Other End-users
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Conduent Inc.
6.1.2 DXC Technology Company
6.1.3 EXL (Scio Health Analytics)
6.1.4 International Business Machines Corporation (IBM)
6.1.6 Northrop Grumman
6.1.7 OSP Labs
6.1.8 SAS Institute
6.1.9 Relx Group PLC (LexisNexis)
6.1.10 United Health Group Incorporated (Optum Inc.)
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
For more information about this report visit https://www.researchandmarkets.com/r/3sddo8